MTOR and sarcoidosis: Of interest, Baker and colleagues found a reduced incidence of sarcoidosis in solid organ transplanted patients when treated with mTOR inhibitors if compared to patients treated with calcineurin inhibitors, suggesting the potential role of mTOR in sarcoidosis pathway (https://doi.org/10.1016/j.semarthrit.2022.152102, accessed on 20 June 2023).